ArticleFrontiers in chemistry2022

Study of the anticancer effect of new quinazolinone hydrazine derivatives as receptor tyrosine kinase inhibitors.

Motahareh Mortazavi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.